Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 638 institutions that hold shares in the stock, with a total of 93.8 Million shares, which have been reported (via 13F filing form) to have a value of $14.4 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,190,708
shares
|
$2.15 Billion
0.04% of portfolio
|
Q2 2024
Added 3.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
9,996,960
shares
|
$1.52 Billion
0.02% of portfolio
|
Q3 2024
Reduced 0.59%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,148,293
shares
|
$782 Million
0.02% of portfolio
|
Q3 2024
Added 11.72%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
2,574,546
shares
|
$391 Million
0.47% of portfolio
|
Q3 2024
Added 4.31%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2024 Q3 2024 |
1,863,800
shares
|
$283 Million
3.62% of portfolio
|
Q3 2024
Reduced 1.83%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,859,232
shares
|
$282 Million
0.02% of portfolio
|
Q3 2024
Added 2.18%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
1,843,281
shares
|
$280 Million
0.3% of portfolio
|
Q3 2024
Added 50.71%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
1,764,590
shares
|
$268 Million
0.04% of portfolio
|
Q3 2024
Added 138.16%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,675,176
shares
|
$254 Million
0.02% of portfolio
|
Q3 2024
Reduced 6.88%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
1,497,931
shares
|
$227 Million
0.01% of portfolio
|
Q3 2024
Reduced 36.6%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,349,381
shares
|
$205 Million
0.01% of portfolio
|
Q3 2024
Reduced 12.65%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
1,347,820
shares
|
$205 Million
0.21% of portfolio
|
Q3 2022
Reduced 8.29%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
1,316,590
shares
|
$200 Million
2.82% of portfolio
|
Q3 2024
Added 90.53%
|
|
|
Dodge & Cox
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
1,287,820
shares
|
$196 Million
0.09% of portfolio
|
Q3 2024
Added 0.55%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,017,154
shares
|
$154 Million
0.02% of portfolio
|
Q3 2024
Reduced 10.19%
|
|
|
Brown Advisory Inc
|
Nov 13, 2024 Q3 2024 |
942,147
shares
|
$143 Million
0.14% of portfolio
|
Q3 2024
Reduced 5.33%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
939,000
shares
|
$143 Million
3.68% of portfolio
|
Q3 2024
Reduced 0.11%
|
|
|
Dsm Capital Partners LLC
Palm Beach Gardens, FL |
Jan 31, 2025 Q4 2024 |
932,595
shares
|
$142 Million
2.21% of portfolio
|
Q4 2024
Reduced 1.22%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
924,416
shares
|
$140 Million
0.1% of portfolio
|
Q2 2023
Added 27.64%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2024 Q3 2024 |
917,674
shares
|
$139 Million
3.0% of portfolio
|
Q3 2024
Added 20.9%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
894,217
shares
|
$136 Million
0.03% of portfolio
|
Q3 2024
Reduced 1.96%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
874,665
shares
|
$133 Million
0.02% of portfolio
|
Q3 2024
Reduced 30.48%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
842,197
shares
|
$128 Million
0.11% of portfolio
|
Q3 2024
Reduced 3.34%
|
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
820,694
shares
|
$125 Million
0.07% of portfolio
|
Q4 2024
Added 145.13%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 08, 2024 Q3 2024 |
819,968
shares
|
$124 Million
0.23% of portfolio
|
Q3 2024
Added 4.74%
|